These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 23891816)
1. S-(N, N-diethylcarbamoyl)glutathione (carbamathione), a disulfiram metabolite and its effect on nucleus accumbens and prefrontal cortex dopamine, GABA, and glutamate: a microdialysis study. Faiman MD; Kaul S; Latif SA; Williams TD; Lunte CE Neuropharmacology; 2013 Dec; 75():95-105. PubMed ID: 23891816 [TBL] [Abstract][Full Text] [Related]
2. N-acetyl-S-(N,N-diethylcarbamoyl) cysteine in rat nucleus accumbens, medial prefrontal cortex, and in rat and human plasma after disulfiram administration. Winefield RD; Heemskerk AA; Kaul S; Williams TD; Caspers MJ; Prisinzano TE; McCance-Katz EF; Lunte CE; Faiman MD J Pharm Biomed Anal; 2015 Mar; 107():518-25. PubMed ID: 25720821 [TBL] [Abstract][Full Text] [Related]
3. Determination of GABA, glutamate and carbamathione in brain microdialysis samples by capillary electrophoresis with fluorescence detection. Kaul S; Faiman MD; Lunte CE Electrophoresis; 2011 Jan; 32(2):284-91. PubMed ID: 21254127 [TBL] [Abstract][Full Text] [Related]
4. The novel α7 nicotinic acetylcholine receptor agonist EVP-6124 enhances dopamine, acetylcholine, and glutamate efflux in rat cortex and nucleus accumbens. Huang M; Felix AR; Flood DG; Bhuvaneswaran C; Hilt D; Koenig G; Meltzer HY Psychopharmacology (Berl); 2014 Dec; 231(23):4541-51. PubMed ID: 24810107 [TBL] [Abstract][Full Text] [Related]
5. Novel δ1-receptor agonist KNT-127 increases the release of dopamine and L-glutamate in the striatum, nucleus accumbens and median pre-frontal cortex. Tanahashi S; Ueda Y; Nakajima A; Yamamura S; Nagase H; Okada M Neuropharmacology; 2012 Apr; 62(5-6):2057-67. PubMed ID: 22266218 [TBL] [Abstract][Full Text] [Related]
6. Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus. Huang M; Li Z; Dai J; Shahid M; Wong EH; Meltzer HY Neuropsychopharmacology; 2008 Nov; 33(12):2934-45. PubMed ID: 18418367 [TBL] [Abstract][Full Text] [Related]
8. Dysregulation of dopamine and glutamate release in the prefrontal cortex and nucleus accumbens following methamphetamine self-administration and during reinstatement in rats. Parsegian A; See RE Neuropsychopharmacology; 2014 Mar; 39(4):811-22. PubMed ID: 23995583 [TBL] [Abstract][Full Text] [Related]
9. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333 [TBL] [Abstract][Full Text] [Related]
10. The metabotropic glutamate receptor 7 (mGluR7) allosteric agonist AMN082 modulates nucleus accumbens GABA and glutamate, but not dopamine, in rats. Li X; Gardner EL; Xi ZX Neuropharmacology; 2008 Mar; 54(3):542-51. PubMed ID: 18155073 [TBL] [Abstract][Full Text] [Related]
11. Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission. Tanahashi S; Yamamura S; Nakagawa M; Motomura E; Okada M Neuropharmacology; 2012 Feb; 62(2):765-74. PubMed ID: 21925189 [TBL] [Abstract][Full Text] [Related]
12. Opposite control of mesocortical and mesoaccumbal dopamine pathways by serotonin Devroye C; Haddjeri N; Cathala A; Rovera R; Drago F; Piazza PV; Artigas F; Spampinato U Neuropharmacology; 2017 Jun; 119():91-99. PubMed ID: 28390892 [TBL] [Abstract][Full Text] [Related]
13. Regulatory system of mGluR group II in the nucleus accumbens for methamphetamine-induced dopamine increase by the medial prefrontal cortex. Haddar M; Uno K; Hamatani K; Muramatsu SI; Nitta A Neuropsychopharmacol Rep; 2019 Sep; 39(3):209-216. PubMed ID: 31283871 [TBL] [Abstract][Full Text] [Related]
14. Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens. Leggio GM; Cathala A; Moison D; Cunningham KA; Piazza PV; Spampinato U Neuropharmacology; 2009 Feb; 56(2):507-13. PubMed ID: 18977370 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of Shati/Nat8l overexpression in the medial prefrontal cortex on methamphetamine-induced conditioned place preference in mice. Haddar M; Uno K; Azuma K; Muramatsu SI; Nitta A Addict Biol; 2020 May; 25(3):e12749. PubMed ID: 30950164 [TBL] [Abstract][Full Text] [Related]
16. Effects of NBI-98782, a selective vesicular monoamine transporter 2 (VMAT2) inhibitor, on neurotransmitter efflux and phencyclidine-induced locomotor activity: Relevance to tardive dyskinesia and antipsychotic action. Huang M; He W; Rajagopal L; Kudwa A; Grigoriadis DE; Meltzer HY Pharmacol Biochem Behav; 2020 Mar; 190():172872. PubMed ID: 32084491 [TBL] [Abstract][Full Text] [Related]
17. Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: a microdialysis study. Allers KA; Dremencov E; Ceci A; Flik G; Ferger B; Cremers TI; Ittrich C; Sommer B J Sex Med; 2010 May; 7(5):1757-67. PubMed ID: 20163532 [TBL] [Abstract][Full Text] [Related]